# Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients

> **NCT04677816** · PHASE2 · RECRUITING · sponsor: **Wake Forest University Health Sciences** · enrollment: 50 (estimated)

## Conditions studied

- Triple Negative Breast Cancer
- Vitamin D Deficiency
- Invasive Breast Cancer

## Interventions

- **DRUG:** Standard of Care Neoadjuvant Chemotherapy (NAC)
- **DIETARY_SUPPLEMENT:** Vitamin D3
- **OTHER:** Drug Diary

## Key facts

- **NCT ID:** NCT04677816
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-22
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04677816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04677816, "Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04677816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*